combination of glutathione and vitamin c Therapy: Your Skin Favourite Combo ✨ Glow that speaks for

During this study, individuals with no significant changes, an increased telomere length (in one case

doi: 10.3389/fmicb.2021.689958 163 MathipaMGThantshaMS

The companion Phase 2 type-2-diabetes paper, with dulaglutide as the active comparator

Trial data consistently show the combination arms exceeding cagrilintide-alone arms 15.6% vs 8.1% at 32 weeks in the Phase 2 diabetes trial (Frias et al., 2023), and a 22.7% combination figure at 68 weeks in REDEFINE 1 (Aronne et al., 2025)

This determination was based on chronic toxicity studies, genotoxicity studies, and human clinical trial safety data

An overall comparison among the four treatment groups was performed using anova or the KruskalWallis test